Dr. Kristin Leigh Bixel, MD

Dr. Bixel practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bixel's NPI, 1801023122, was assigned on June 12, 2009. Dr. Bixel graduated from UCSF School of Medicine in 2009. Dr. Bixel holds California license C197911.

Dr. Bixel's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bixel's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Bixel is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bixel to 1 more hospital and 1 medical group, each named with a free account. Dr. Bixel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bixel practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Bixel's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Bixel is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Bixel's licenses on file in 3 states: California, Ohio and Massachusetts.

Dmand AI lists hysterectomy among the conditions Dr. Bixel treats.

CMS data shows 206 Medicare services from Dr. Bixel across 5 procedure codes in 2024, for 122 Medicare patients. Medicare paid $15,842 for them.

CMS counts 122 Medicare patients who saw Dr. Bixel in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bixel's median patient age at 61, with 98% women.

In 2024, Dr. Bixel wrote 55 Medicare Part D claims for 25 patients. 87% of them were for generic drugs. CMS names the drug for 38 of them, across 1 drug with 11 or more claims each, at $594 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Dr. Bixel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bixel as offering telehealth. CMS counts 11 procedures of removal of the uterus by Dr. Bixel, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 52 papers to Dr. Bixel, published from 2011 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Endometrial Neoplasms, Ovarian Neoplasms and Hysterectomy. Dr. Bixel has published most often in Gynecol Oncol. Dr. Bixel's most frequent co-authors are Larry J. Copeland, MD, Christa Irene Nagel, MD and Monica Dandapani Levine, MD, MS.

Dmand AI links Dr. Bixel to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms and Ovarian Diseases.

CMS Open Payments shows 13 general payments to Dr. Bixel from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $237.

Dr. Bixel graduated from UCSF School of Medicine in 2009.

Dr. Bixel is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.